Lamazym Aftercare Study FR Designed to Provide Treatment for French Patients

Exclusion Criteria

• •Presence of known clinically significant cardiovascular, hepatic, pulmonary, or renal disease or other medical conditions that, in the opinion of the Investigator, would preclude participation in the trial
• •Any other medical condition or serious intercurrent illness, or extenuating circumstances that, in the opinion of the Investigator, would preclude participation in the trial
• •Pregnancy. Pregnant woman is excluded. Before start fot he treatment the investigators will for women of childbearing potential perform a pregnancy test and decide whether or not there is a need for contraception
• •Planned major surgery that, in the opinion of the Investigator, would preclude participation in the trial
• •Adult patients who, in the opinion of the Investigator, would be unable to give consent, and who does not have any legal protection or guardianship
• •total IgE \> 800 IU/mL
• •Known allergy to the IMP or any excipients (Sodium-Phosphate, Glycine, Mannitol)